Zdrowie i gospodarka · 30/09/1998

FDA Releases Draft Guidance for Investigating Out of Specification Test Results in Pharmaceutical Production

The Food and Drug Administration (FDA) has made available a draft guidance document that outlines steps for the pharmaceutical industry to take when analytical test results exceed specifications during production, helping to ensure the quality and safety of pharmaceuticals.